Suppr超能文献

通过在低纳米颗粒与细胞比例下的单粒子追踪,实现荧光标记脂质纳米颗粒与特异性标记的亚细胞区室的共定位。

Co-localization of fluorescent labeled lipid nanoparticles with specifically tagged subcellular compartments by single particle tracking at low nanoparticle to cell ratios.

作者信息

Tiffany Matthew, Szoka Francis C

机构信息

a Department of Bioengineering, Therapeutic Sciences and Pharmaceutical Chemistry , University of California , San Francisco , CA , USA.

b Department of Pediatrics and Genetics , Stanford University School of Medicine , Stanford , CA , USA.

出版信息

J Drug Target. 2016 Nov;24(9):857-864. doi: 10.1080/1061186X.2016.1233976. Epub 2016 Sep 30.

Abstract

We utilized quantitative high-resolution single particle tracking to study the internalization and endosomal sorting of lipid nanoparticles (LNPs) by HeLa cells in vitro to gain a better understanding of how cells process LNPs that are used for siRNA delivery. We compared the trafficking of three formulations that have been demonstrated to deliver siRNA into cells. They were composed of either a tritratable anionic lipid, formulation of cholesterol hemisuccinate (CHEMS), or a titratatable cationic lipid formulation of 1,2-dilinoleyloxy-3-dimethylaminopropane (DLinDMA) or a non-titratable cationic formulation lipid formulation of 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP). They also contained either a substantial percentage of 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) or cholesterol and 5 mole percent 1,2-dimyristoyl-sn-glycerol-[methoxy(polyethylene glycol)-2000 (PEG-DMG). We optically measured the endosomal pH experienced by individual LNPs, observed the internalization pathways used and tracked the particles as they co-localized with fluorescent protein tags on compartment-specific proteins, during endosomal sorting to the lysosome. The data revealed significant differences in the accumulation in subcellular compartments among the three formulations, which help to explain the observed effects LNP composition exerts on in vitro delivery efficiency.

摘要

我们利用定量高分辨率单粒子追踪技术,在体外研究脂质纳米颗粒(LNP)被HeLa细胞内化和内体分选的过程,以更好地了解细胞如何处理用于递送小干扰RNA(siRNA)的LNP。我们比较了三种已被证明能将siRNA递送至细胞内的制剂的运输情况。它们分别由可滴定的阴离子脂质胆固醇半琥珀酸酯(CHEMS)制剂、可滴定的阳离子脂质1,2-二亚油酰氧基-3-二甲基氨基丙烷(DLinDMA)制剂或不可滴定的阳离子脂质1,2-二油酰基-3-三甲基铵丙烷(DOTAP)制剂组成。它们还分别含有相当比例的1,2-二油酰基-sn-甘油-3-磷酸乙醇胺(DOPE)或胆固醇以及5摩尔百分比的1,2-二肉豆蔻酰-sn-甘油-[甲氧基(聚乙二醇)-2000](PEG-DMG)。我们通过光学方法测量了单个LNP所经历的内体pH值,观察了其使用的内化途径,并在LNP内体分选至溶酶体的过程中,追踪了与特定区室蛋白上的荧光蛋白标签共定位的颗粒。数据显示,这三种制剂在亚细胞区室中的积累存在显著差异,这有助于解释所观察到的LNP组成对体外递送效率的影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验